Cargando…
Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency
IL-15 supports improved antitumor immunity. How to best incorporate IL-15 into vaccine formulations for superior cancer immunotherapy remains a challenge. DC-derived IL-15 (DCIL-15) notably has the capacity to activate DC, to substitute for CD4(+) Th and to potentiate vaccine efficacy making IL-15-b...
Autores principales: | Zhang, Yi, Tian, Shenghe, Liu, Zuqiang, Zhang, Jiying, Zhang, Meili, Bosenberg, Marcus W, Kedl, Ross M, Waldmann, Thomas A, Storkus, Walter J, Falo, Louis D, You, Zhaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292719/ https://www.ncbi.nlm.nih.gov/pubmed/25941586 http://dx.doi.org/10.4161/21624011.2014.959321 |
Ejemplares similares
-
Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitors
por: Hao, Xingxing, et al.
Publicado: (2021) -
Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases
por: Waldmann, Thomas A
Publicado: (2004) -
Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands
por: Versteven, Maarten, et al.
Publicado: (2022) -
Therapeutic effectiveness of intratumorally-delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32
por: Qu, Yanyan, et al.
Publicado: (2011) -
Extranodal induction of therapeutic immunity in the tumor
microenvironment after intratumoral delivery of Tbet
gene-modified dendritic cells
por: Chen, Lu, et al.
Publicado: (2013)